Loading organizations...
§ Private Profile · Haidian, Beijing, China
Guoke Ion is an innovative enterprise focusing on the integration of advanced medical technology and financial services.
Guoke Ion is an innovative enterprise founded in 2018, with its headquarters located in Haidian, Beijing, China. The company distinguishes itself through a strategic focus on integrating advanced medical technology with financial services, aiming to deliver comprehensive solutions to the healthcare market.
Guoke Ion has raised $115.2M across 1 funding round.
Guoke Ion is involved in the development and supply of advanced medical equipment, including CT, gamma knife, linac, and carbon ion therapy systems.
The company's strategy involves combining advanced medical technology with financial services, indicating a comprehensive approach to market engagement and the economic aspects of healthcare solutions.
Guoke Ion was founded in 2018 and is headquartered in Haidian, Beijing, China.
Guoke Ion is involved in the development and supply of advanced medical equipment, including CT, gamma knife, linac, and carbon ion therapy systems.
The company's strategy involves combining advanced medical technology with financial services, indicating a comprehensive approach to market engagement and the economic aspects of healthcare solutions.
Guoke Ion was founded in 2018 and is headquartered in Haidian, Beijing, China.
Within the medical technology sector, Guoke Ion is active in the development and application of various advanced equipment. This includes its involvement with technologies such as CT, gamma knife, linac, and carbon ion therapy systems, positioning it among competitive entities in China's particle therapy equipment market.
The company's approach to combining medical technology with financial services suggests a strategy to not only innovate in healthcare devices but also to address the economic and market aspects of these solutions. This dual focus allows Guoke Ion to engage with the healthcare ecosystem from multiple perspectives.
Guoke Ion's establishment in 2018 reflects its relatively recent entry into the market, yet its stated focus on advanced medical technologies indicates an ambition to contribute to the evolving landscape of medical device manufacturing and healthcare delivery.
Its presence alongside other established medical technology companies in China highlights its role in fostering domestic capabilities in high-tech medical equipment. The company's efforts are part of a broader trend towards enhancing the country's medical technology infrastructure and offering advanced treatment options.
Guoke Ion has raised $115.2M across 1 funding round. Most recently, it raised $115.2M Series A in February 2026.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Feb 2, 2026 | $115.2M Series A | Legend Capital, National Council For Social Security Fund | Xiamen ITG Group | Announced |